Tamam, Y. Et Al. 2020. Serum levels of inflammasome pathway factors in clinically isolated syndrome and multiple sclerosis patients: a pilot study. CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY , vol.45, no.2 , 237-240.

Tamam, Y., Yuceer, H., Duzel, B., Sen, M., Ulusoy, C., & Tuzun, E., (2020). Serum levels of inflammasome pathway factors in clinically isolated syndrome and multiple sclerosis patients: a pilot study. CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY , vol.45, no.2, 237-240.

Tamam, Yusuf Et Al. "Serum levels of inflammasome pathway factors in clinically isolated syndrome and multiple sclerosis patients: a pilot study," CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY , vol.45, no.2, 237-240, 2020

Tamam, Yusuf Et Al. "Serum levels of inflammasome pathway factors in clinically isolated syndrome and multiple sclerosis patients: a pilot study." CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY , vol.45, no.2, pp.237-240, 2020

Tamam, Y. Et Al. (2020) . "Serum levels of inflammasome pathway factors in clinically isolated syndrome and multiple sclerosis patients: a pilot study." CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY , vol.45, no.2, pp.237-240.

@article{article, author={Yusuf Tamam Et Al. }, title={Serum levels of inflammasome pathway factors in clinically isolated syndrome and multiple sclerosis patients: a pilot study}, journal={CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY}, year=2020, pages={237-240} }